tm logo
CRISPR BY DESIGN
Live/Pending
FOURTH EXTENSION - GRANTED

granted

on 16 Dec 2024

Last Applicant/ Owned by

1150 Marina Village Parkway

Alameda

CA

94501

Serial Number

90596751 filed on 23rd Mar 2021

Registration Number

N/A

Correspondent Address

John Paul Oleksiuk

John Paul Oleksiuk COOLEY LLP

WASHINGTON, DC 20004

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

CRISPR BY DESIGN

Molecular diagnostic testing, monitoring and reporting services for medical purposes and medical research purposes; Medical diagnostic testing services in the field of human disease and human medical conditions Pharmaceutical and biological preparations based on genetic engineering and gene therapy for use in diagnosis, prevention, and treatment of diseases in human therapeuticsin the nature of d Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical and biological preparations based on genetic engineering and gene therapy for use in diagnosis, prevention, and treatment of diseases in human therapeuticsin the nature of diseases caused by genetic mutations or for which gene modification would ameliorate or cure the disease or disorder; Gene therapy products, namely, biological preparations based on engineered cells for medical use for the treatment of diseases caused by genetic mutations or for which gene modification would ameliorate or cure the disease or disorder related to immuno-oncology, degenerative disorders, traumatic injury, enzyme replacement therapy, and immunology; Pharmaceutical and biological preparations based on gene, genome, and cellular editing, modulation, and modification for use in human therapeutics in the nature of diseases caused by genetic mutations or for which gene modification would ameliorate or cure the disease or disorder; Pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders, namely, neurological disorders, Huntington's disease, amyotrophic lateral sclerosis (ALS), front temporal dementia, pain, Alzheimer's, Parkinson's, ataxia, autism, epilepsy, pain, and also cardiovascular, peripheral nervous system, cancer, endocrine, gastrointestinal, renal, genetic immunological, hepatic, infectious, inflammatory, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, respiratory, urogenital, urological, hematologic and viral or bacterial diseases and disorders


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [044]
Medical, Beauty & Agricultural Services


Molecular diagnostic testing, monitoring and reporting services for medical purposes and medical research purposes; Medical diagnostic testing services in the field of human disease and human medical conditions


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 90596751

Mark Type

No Service Mark

Attorney Docket Number

No 333322.20000

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
16th Dec 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
16th Dec 2024DIVISIONAL PROCESSING COMPLETE
16th Dec 2024CORRECTED NOA E-MAILED
16th Dec 2024SOU EXTENSION 4 GRANTED
22nd Nov 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
18th Nov 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
23rd Oct 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
19th Aug 2024TEAS REQUEST TO DIVIDE RECEIVED
19th Aug 2024DIVISIONAL REQUEST RECEIVED
14th Aug 2024SOU TEAS EXTENSION RECEIVED